Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?Zacks Investment Research • 07/07/26
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma GiantThe Motley Fool • 07/02/26
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?The Motley Fool • 07/01/26
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 CoverageZacks Investment Research • 07/01/26
Pfizer (PFE) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 06/30/26
Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat24/7 Wall Street • 06/30/26
Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.Market Watch • 06/29/26
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right NowThe Motley Fool • 06/27/26
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly DividendsThe Motley Fool • 06/27/26
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder CancerZacks Investment Research • 06/25/26
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline MaintenanceBusiness Wire • 06/24/26